Anthony Fauci, MD, director, National Institute of Allergy and Infectious Diseases, Bethesda, MD.
Mark Denison, MD, director, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville.
George Painter, PhD, chief executive officer, Drug Innovation Ventures at Emory, Emory University, Atlanta.
ClinicalTrials.gov, accessed Feb. 17, 2020.
Cell Research: “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.”
The New England Journal of Medicine: “First Case of 2019 Novel Coronavirus in the United States.”
Journal of Virology, Feb. 3, 2020.
World Health Organization: “Clinical management of severe acute respiratory infection when novel coronavirus infection is suspected.”